Fateme Haghiralsadat
4PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 01, 2023
Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted PLK1 siRNAs for treating bladder cancer.Maryamsadat Shahidi, Omid Abazari, Parisa Dayati
|Jul 24, 2018
Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy.Mahdie Hemati, Fateme Haghiralsadat, Fatemeh Yazdian
|Feb 25, 2018
Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.Fateme Haghiralsadat, Ghasem Amoabediny, Samira Naderinezhad
|Jan 26, 2017
New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity.Fateme Haghiralsadat, Ghasem Amoabediny, Mohammad Hasan Sheikhha
Pageof 1
Frequent Collaborators
1 joint publications
Maryamsadat Shahidi
1 joint publications
Omid Abazari
1 joint publications
Parisa Dayati
1 joint publications
Javad Zavar Reza
1 joint publications
Mohammad Hossein Modarressi
1 joint publications
Davood Tofighi
1 joint publications
Fatemeh Oroojalian
1 joint publications
Samira Naderinezhad
1 joint publications
Behrouz Zandieh-Doulabi
